Kadyshev VV (2026). [PMID: 41847810](https://pubmed.ncbi.nlm.nih.gov/41847810/). *Vestn Oftalmol*. [Basic Science / Preclinical]
Kadyshev VV (2026). [PMID: 41847811](https://pubmed.ncbi.nlm.nih.gov/41847811/). *Vestn Oftalmol*. [Epidemiology / Natural History]
Liu B (2025). [PMID: 40023307](https://pubmed.ncbi.nlm.nih.gov/40023307/). *Exp Eye Res*. [Basic Science / Preclinical]
Maalej B (2025). [PMID: 41191260](https://pubmed.ncbi.nlm.nih.gov/41191260/). *Indian J Pediatr*. [Other]
Kılıç KC (2025). [PMID: 39705870](https://pubmed.ncbi.nlm.nih.gov/39705870/). *Tissue Cell*. [Gene Therapy / Novel Therapeutics]
Fehilly JD (2025). [PMID: 40552921](https://pubmed.ncbi.nlm.nih.gov/40552921/). *FASEB J*. [Diagnostic / Biomarker]
Issa M (2025). [PMID: 38470931](https://pubmed.ncbi.nlm.nih.gov/38470931/). *Retin Cases Brief Rep*. [Case Report / Case Series]
Damodar K (2024). [PMID: 39385467](https://pubmed.ncbi.nlm.nih.gov/39385467/). *Mol Ther*. [Gene Therapy / Novel Therapeutics]
Bianco L (2024). [PMID: 38945349](https://pubmed.ncbi.nlm.nih.gov/38945349/). *Am J Ophthalmol*. [Review / Meta-Analysis]
Kvanta A (2024). [PMID: 39256350](https://pubmed.ncbi.nlm.nih.gov/39256350/). *Nat Commun*. [Clinical Trial Publication]
